Skip to main content
. Author manuscript; available in PMC: 2022 Feb 3.
Published in final edited form as: J Expo Sci Environ Epidemiol. 2021 May 6;31(3):476–486. doi: 10.1038/s41370-021-00335-3

Table 2.

The agonistic, antagonistic, and partial agonist activities of 1g of product presented as hormonal equivalent concentrations relative to their respective positive controls.

RGA Sample 1 (Hair lotion) Sample 2 (Leave-in conditioner) Sample 3 (Leave-in conditioner) Sample 4 (Hair oil) Sample 5 (Root stimulator) Sample 6 (Hair oil)
Estrogen Agonist with additive response 12.5–20ng/g EEQ No response observed Partial agonist:
Agonist
5–7.5ng/g EEQ Antagonist reducing EEQ by 20–25ng/g
Antagonist reducing EEQ by 22.5–25ng/g Agonist 15ng/g EEQ Antagonist – difficult to estimate due to toxicity. reducing EEQ by 25ng/g (in all dilutions)
Androgen No response observed Antagonist reducing TEQ by 145ng/g Antagonist reducing TEQ by 145ng/g Antagonist reducing TEQ by 131ng/g No response observed Antagonist reducing TEQ by 145ng/g
Progesterone Antagonist reducing PEQ by 75ng/g Partial agonist:
Agonist 250ng/g PEQ Antagonist reducing PEQ by 125ng/g
Antagonist reducing PEQ by 200ng/g Partial agonist:
Agonist 50ng/g PEQ Antagonist reducing PEQ by 175–225ng/g
No response observed No response observed
Glucocorticoid No response observed Antagonist reducing GEQ by 2500ng/g Antagonist reducing GEQ by 2000ng/g Antagonist reducing GEQ by 15002000ng/g Antagonist reducing GEQ by 500ng/g No response observed

Abbreviations: EEQ, Estrogen Equivalents of 17beta-estradiol; TEQ, Testosterone Equivalents of testosterone; PEQ, Progesterone Equivalents of progesterone; GEQ, Glucocorticoid Equivalents of hydrocortisol